Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease
- PMID: 20865675
Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is considered the liver component of the metabolic syndrome. We investigated the diastolic and systolic functional parameters of patients with NAFLD and the impact of metabolic syndrome on these parameters.
Methods: Thirty-five non-diabetic, normotensive NAFLD patients, and 30 controls, were included in this study. Each patient underwent transthoracic conventional and tissue Doppler echocardiography (TDI) for the assessment of left ventricular (LV) diastolic and systolic function. Study patients were also evaluated with 24-hour ambulatory blood pressure monitoring.
Results: NAFLD patients had higher blood pressures, increased body mass indices, and more insulin resistance than controls. TDI early diastolic velocity (E' on TDI) values were lower in NAFLD patients than the controls (11.1 ± 2.1 vs 15.3 ± 2.7; p < 0.001). TDI systolic velocity (S' on TDI) values were lower in NAFLD patients than the controls (9.34 ± 1.79 vs 10.6 ± 1.52; p = 0.004). E' on TDI and S' on TDI values were moderately correlated with night-systolic blood pressure, night-diastolic blood pressure, and night-mean blood pressure in NAFLD patients.
Conclusions: Patients with NAFLD have impaired LV systolic and diastolic function even in the absence of morbid obesity, hypertension, or diabetes.
Similar articles
-
Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment.J Clin Gastroenterol. 2006 Nov-Dec;40(10):949-55. doi: 10.1097/01.mcg.0000225668.53673.e6. J Clin Gastroenterol. 2006. PMID: 17063117
-
Left ventricular function by echocardiography, tissue Doppler imaging, and carotid intima-media thickness in obese adolescents with nonalcoholic fatty liver disease.Am J Cardiol. 2013 Aug 1;112(3):436-43. doi: 10.1016/j.amjcard.2013.03.056. Epub 2013 Apr 30. Am J Cardiol. 2013. PMID: 23642511
-
Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease.Hepatology. 2014 Feb;59(2):461-70. doi: 10.1002/hep.26610. Epub 2013 Dec 23. Hepatology. 2014. PMID: 23843206
-
Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.Dan Med Bull. 2001 Nov;48(4):199-210. Dan Med Bull. 2001. PMID: 11767125 Review.
-
Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysis.Hepatol Int. 2022 Apr;16(2):269-281. doi: 10.1007/s12072-022-10319-6. Epub 2022 Mar 23. Hepatol Int. 2022. PMID: 35320497 Review.
Cited by
-
Significant Association Between Left Ventricular Diastolic Dysfunction, Left Atrial Performance and Liver Stiffness in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease.Diabetes Metab Syndr Obes. 2021 Apr 9;14:1535-1545. doi: 10.2147/DMSO.S300450. eCollection 2021. Diabetes Metab Syndr Obes. 2021. PMID: 33859484 Free PMC article.
-
Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations.J Clin Transl Hepatol. 2020 Mar 28;8(1):76-86. doi: 10.14218/JCTH.2019.00051. Epub 2019 Dec 28. J Clin Transl Hepatol. 2020. PMID: 32274348 Free PMC article. Review.
-
From NAFLD to MASLD: Meta-analysis and systematic review of NAFLD patients in Turkiye in terms of metabolic profile and MASLD potential.Hepatol Forum. 2024 Jul 2;5(3):126-138. doi: 10.14744/hf.2023.2023.0042. eCollection 2024. Hepatol Forum. 2024. PMID: 39006144 Free PMC article. Review.
-
Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study).PLoS One. 2015 Nov 16;10(11):e0142937. doi: 10.1371/journal.pone.0142937. eCollection 2015. PLoS One. 2015. PMID: 26571029 Free PMC article.
-
The association of hepatic steatosis and fibrosis with heart failure and mortality.Cardiovasc Diabetol. 2021 Sep 28;20(1):197. doi: 10.1186/s12933-021-01374-8. Cardiovasc Diabetol. 2021. PMID: 34583706 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources